Erika Santos Horta, MD

Associate Member

Research Program:

Developmental Therapeutics

Faculty Rank:

Assistant Research Professor

Campus:

University of Arkansas for Medical Sciences

College:

College of Medicine

Department:

Neurology

Cancer Research Interest

Disease Site Focus: Brain
Research Focus Area: Treatment, Diagnosis/ Prognosis
Research Keywords: brain tumors, neurofibromatosis, gliomas, meningiomas, clinical trials
Type of Research: Clinical
Research Interest Statement: My mission is to improve the care of patients with brain tumors through developing clinical trials, disseminating knowledge and by listening to my patients experiences.

“A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Phase 2Dose-Response Study to Determine Safety and Effectiveness of Two Concentrations of NFX-179 Gel in Subjects with Cutaneous Neurofibromas” (NCT05005845)
“Cladribine tablets: Observational evaluation of effectiveness and patient-reported outcomes (PROs) in suboptiMAlly controlled patientS previously Taking oral or infusion disEase-modifying dRugs (DMDs) for relapsing forms of multiple sclerosis (RMS) (MASTER-2)” (NCT03933202)
“CLadribine tablets: Observational evaluation of effectIveness and patient-reported outcomes (PROs) in suboptimally Controlled patients previously taKing injectable disease-modifying drugs (DMDs) for relapsing forms of Multiple Sclerosis (RMS) (CLICK-MS)” (NCT03933215)

NRG Oncology Foundation – NRG-BN007
“NRG-BN007”
Principal Investigator
08/06/21 – 08/05/22

Horta E, Bongiorno C, Ezzeddine M, Neil EC. Neurotoxicity of antibodies in cancer therapy: A review. Clinical neurology and neurosurgery. 2020 188:105566. PMID: 31731087.